Takemoto Jon Y, Altenberg Guillermo A, Poudyal Naveena, Subedi Yagya P, Chang Cheng-Wei T
Department of Biology, Utah State University, Logan, UT, United States.
Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Front Microbiol. 2022 Sep 23;13:1000199. doi: 10.3389/fmicb.2022.1000199. eCollection 2022.
Widely-used -derived antibacterial aminoglycosides have encountered challenges because of antibiotic resistance and toxicity. Today, they are largely relegated to medicinal topical applications. However, chemical modification to amphiphilic aminoglycosides can revive their efficacy against bacterial pathogens and expand their targets to other pathogenic microbes and disorders associated with hyperactive connexin hemichannels. For example, amphiphilic versions of neomycin and neamine are not subject to resistance and have expanded antibacterial spectra, and amphiphilic kanamycins are effective antifungals and have promising therapeutic uses as connexin hemichannel inhibitors. With further research and discoveries aimed at improved formulations and delivery, amphiphilic aminoglycosides may achieve new horizons in pharmacopeia and agriculture for aminoglycosides beyond just serving as topical antibacterials.
广泛使用的衍生抗菌氨基糖苷类药物由于抗生素耐药性和毒性而面临挑战。如今,它们主要用于药用局部应用。然而,对两亲性氨基糖苷类药物进行化学修饰可以恢复其对细菌病原体的疗效,并将其靶点扩展到其他致病微生物以及与连接蛋白半通道过度活跃相关的疾病。例如,新霉素和新霉胺的两亲性版本不易产生耐药性,且抗菌谱有所扩大,两亲性卡那霉素是有效的抗真菌药物,作为连接蛋白半通道抑制剂具有广阔的治疗应用前景。随着旨在改进制剂和给药方式的进一步研究和发现,两亲性氨基糖苷类药物可能会在药典和农业领域为氨基糖苷类药物开辟新的前景,而不仅仅是作为局部抗菌药物。